NO20042002L - Farmasoytiske preparater basert pa mikronisert progesteron, deres fremstilling og anvendelse - Google Patents

Farmasoytiske preparater basert pa mikronisert progesteron, deres fremstilling og anvendelse

Info

Publication number
NO20042002L
NO20042002L NO20042002A NO20042002A NO20042002L NO 20042002 L NO20042002 L NO 20042002L NO 20042002 A NO20042002 A NO 20042002A NO 20042002 A NO20042002 A NO 20042002A NO 20042002 L NO20042002 L NO 20042002L
Authority
NO
Norway
Prior art keywords
oil
preparation
pharmaceutical preparations
micronized progesterone
preparations based
Prior art date
Application number
NO20042002A
Other languages
English (en)
Other versions
NO335044B1 (no
Inventor
Antoine Besins
Jerome Besse
Original Assignee
Besins Int Belgique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Int Belgique filed Critical Besins Int Belgique
Publication of NO20042002L publication Critical patent/NO20042002L/no
Publication of NO335044B1 publication Critical patent/NO335044B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NO20042002A 2001-11-13 2004-05-14 Farmasøytiske preparater basert på mikronisert progesteron, fremgangsmåte for deres fremstilling og anvendelse. NO335044B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0114653A FR2832065B1 (fr) 2001-11-13 2001-11-13 Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations
PCT/FR2002/003879 WO2003041720A1 (fr) 2001-11-13 2002-11-13 Composition pharmaceutique a base de progesterone micronisee, son procede de preparation et ses utilisations

Publications (2)

Publication Number Publication Date
NO20042002L true NO20042002L (no) 2004-05-14
NO335044B1 NO335044B1 (no) 2014-09-01

Family

ID=8869332

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042002A NO335044B1 (no) 2001-11-13 2004-05-14 Farmasøytiske preparater basert på mikronisert progesteron, fremgangsmåte for deres fremstilling og anvendelse.

Country Status (25)

Country Link
US (5) US20030092691A1 (no)
EP (1) EP1443940B1 (no)
KR (1) KR100911790B1 (no)
CN (1) CN1263453C (no)
AT (1) ATE339958T1 (no)
AU (1) AU2002352334B2 (no)
BR (1) BRPI0214043B8 (no)
CY (1) CY1106293T1 (no)
DE (1) DE60214876T2 (no)
DK (1) DK1443940T3 (no)
EA (1) EA006550B1 (no)
ES (1) ES2272793T3 (no)
FR (1) FR2832065B1 (no)
HK (1) HK1064606A1 (no)
HU (1) HU229341B1 (no)
IL (2) IL161668A0 (no)
MA (1) MA27081A1 (no)
NO (1) NO335044B1 (no)
NZ (1) NZ532659A (no)
OA (1) OA12726A (no)
PL (1) PL206096B1 (no)
PT (1) PT1443940E (no)
UA (1) UA77451C2 (no)
WO (1) WO2003041720A1 (no)
ZA (1) ZA200403288B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2832065B1 (fr) 2001-11-13 2004-11-05 Besins Int Belgique Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations
PT2279729T (pt) * 2003-07-17 2016-09-22 Banner Life Sciences Llc Preparações de libertação controlada
ATE543489T1 (de) * 2005-05-26 2012-02-15 Teva Womens Health Inc Orale dosierformen mit progesteron und verwendungs- und herstellungsverfahren dafür
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
DE202007019049U1 (de) * 2007-11-05 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Verwendung eines Gestagens in Kombination mit einem Estrogen zur Prophylaxe der Laktoseintoleranz bei der oralen Kontrazeption
FR2947178B1 (fr) 2009-06-29 2012-07-06 Effik Composition pharmaceutique a base de progesterone micronisee et ses utilisations
CN102091054B (zh) * 2009-12-14 2014-04-16 浙江爱生药业有限公司 黄体酮制剂组合物及其制备方法
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
WO2013037650A1 (fr) * 2011-09-15 2013-03-21 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
CA2850187C (en) * 2011-09-29 2021-12-07 Plx Pharma Inc. Ph dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
AU2015296609A1 (en) 2014-07-29 2016-12-22 Therapeuticsmd, Inc. Transdermal cream
MX2017016823A (es) 2015-06-22 2018-03-12 Lipocine Inc Composiciones orales que contienen éster de 17- hydroxiprogesterona y métodos relacionados.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
EP3395332A1 (en) 2017-04-28 2018-10-31 Chemo Research, S.L. Hormone softgel capsules and a process for the preparation thereof
US10285998B1 (en) 2018-04-04 2019-05-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
MX2022011743A (es) 2020-03-26 2022-12-08 Plx Opco Inc Portadores farmaceuticos con capacidad de reconstitucion dependiente del ph y metodos para elaborar y usar los mismos.
EP4389117A1 (en) 2022-12-19 2024-06-26 Besins Healthcare Distribution FZ-LLC Progesterone formulation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
JPS60258110A (ja) * 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液
US5140021A (en) * 1986-04-16 1992-08-18 Genesis Systems Corporation Method and dosage form for treatment of premenstrual syndrome
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
IT1256386B (it) * 1992-11-13 1995-12-04 Luigi Boltri Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo
EP0664112B1 (fr) * 1993-12-22 1997-03-26 L'oreal Poudre cosmétique ou dermatologique, son procédé de préparation et utilisations
FR2747042B1 (fr) * 1996-04-05 1998-06-05 Besins Iscovesco Lab Medicament a base de progesterone et d'oestradiol
GB9608719D0 (en) * 1996-04-26 1996-07-03 Scherer Ltd R P Pharmaceutical compositions
CA2253673C (en) * 1996-05-01 2009-09-08 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services 21-substituted progesterone derivatives as new antiprogestational agents
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone
FR2832065B1 (fr) * 2001-11-13 2004-11-05 Besins Int Belgique Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations

Also Published As

Publication number Publication date
US7431941B2 (en) 2008-10-07
US20050004076A1 (en) 2005-01-06
ES2272793T3 (es) 2007-05-01
WO2003041720A1 (fr) 2003-05-22
FR2832065A1 (fr) 2003-05-16
DK1443940T3 (da) 2007-01-29
KR100911790B1 (ko) 2009-08-12
BRPI0214043B8 (pt) 2021-05-25
UA77451C2 (en) 2006-12-15
KR20050058231A (ko) 2005-06-16
IL161668A (en) 2009-09-01
OA12726A (en) 2006-06-27
HK1064606A1 (no) 2005-02-04
US20030092691A1 (en) 2003-05-15
CN1263453C (zh) 2006-07-12
CY1106293T1 (el) 2011-10-12
BR0214043A (pt) 2004-10-13
EA006550B1 (ru) 2006-02-24
US8435561B2 (en) 2013-05-07
US20090123534A1 (en) 2009-05-14
NZ532659A (en) 2006-04-28
AU2002352334B2 (en) 2008-10-23
ZA200403288B (en) 2005-07-27
DE60214876D1 (de) 2006-11-02
EA200400668A1 (ru) 2004-10-28
PL369131A1 (en) 2005-04-18
EP1443940B1 (fr) 2006-09-20
DE60214876T2 (de) 2007-04-05
HUP0401935A2 (hu) 2005-01-28
HUP0401935A3 (en) 2011-02-28
PL206096B1 (pl) 2010-06-30
FR2832065B1 (fr) 2004-11-05
HU229341B1 (en) 2013-11-28
US20120276194A1 (en) 2012-11-01
CN1585644A (zh) 2005-02-23
IL161668A0 (en) 2004-09-27
US20110135719A1 (en) 2011-06-09
PT1443940E (pt) 2007-01-31
US7829115B2 (en) 2010-11-09
MA27081A1 (fr) 2004-12-20
NO335044B1 (no) 2014-09-01
EP1443940A1 (fr) 2004-08-11
BRPI0214043B1 (pt) 2019-12-31
ATE339958T1 (de) 2006-10-15

Similar Documents

Publication Publication Date Title
NO20042002L (no) Farmasoytiske preparater basert pa mikronisert progesteron, deres fremstilling og anvendelse
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
UY26130A1 (es) Compuestos para tratar la obesidad
ATE472551T1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
DE60331236D1 (de) Orale zusammensetzungen zur behandlung von diabetes
ATE291433T1 (de) Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen
RS74403A (en) Derivatives of n-(arylslfonyl)beta- aminoacids comprising a supstituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
MXPA05013824A (es) Inhibidores de quinasa p38 basados en heterociclos de 5 miembros.
AU2002351593A1 (en) Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
HK1080764A1 (en) Implant for transport and release for pharmacologically active agents as well as a process for producing the same
DK1328276T3 (da) Anvendelse af antiprogestiner til profylakse og behandling af hormonafhængige sygdomme
WO2003045334A3 (en) Methods and compositions for ameliorating the undesirable effects of chemotherapy
BRPI0407693A (pt) uso de esteróides para preparação de formulações utilizáveis no tratamento de pessoas sofrendo de distúrbios oculares, bem como formulação assim obtidos
DK1525215T3 (da) Modulatorer for receptoren for progesteron med forhöjet anti-gonadotrop aktivitet til fertilitetskontrol hos kvinder og ved terapi til erstatning af hormoner
WO2004030631A3 (en) Anti-cancer and anti-infectious disease compositions and methods for using same
BRPI0407742A (pt) uso de glicocorticóides para preparação de formulação utilizáveis no tratamento de angiogênese ocular patológica, bem como formulção assim obtida
DE60107441D1 (de) Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von dysphorie
MXPA04006047A (es) Composicion farmaceutica para prevencion y tratamiento de eyaculacion precoz y/o hipersensibilidad durante la estimulacion sexual.
WO2004011029A3 (en) Pharmaceutical compositions for penis enlargement
HUP0202460A2 (hu) A mezoprogesztinek (progeszteron-receptor-modulátorok), mint hormonpótlásos kezelésre alkalmas készítmények komponensei
WO2004103291A3 (en) Extended release compositions of proton pump inhibitor
GEU2003988Y (en) Ointment for Treatment of Burns and Wounds
MD2164F1 (en) Method of treatment of ocular contusions
ATE543510T1 (de) Bowman-birk-hemmer-zusammensetzungen zur behandlung von muskelatrophie und degenerativer muskelerkrankung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
RE Reestablishment of rights (par. 72 patents act)
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BESINS HEALTCARE LUXEMBOURG SARL, LU

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BESINS HEALTHCARE LUXEMBOURG SARL, LU

MK1K Patent expired